Andlauer Capex To Revenue from 2010 to 2024
| AND Stock | CAD 42.80 0.16 0.38% |
Capex To Revenue | First Reported 2010-12-31 | Previous Quarter 0.03949675 | Current Value 0.0213 | Quarterly Volatility 0.01615305 |
Check Andlauer Healthcare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Andlauer Healthcare's main balance sheet or income statement drivers, such as Tax Provision of 16.2 M, Interest Income of 3 M or Depreciation And Amortization of 41 M, as well as many indicators such as Price To Sales Ratio of 2.66, Dividend Yield of 0.0079 or PTB Ratio of 3.47. Andlauer financial statements analysis is a perfect complement when working with Andlauer Healthcare Valuation or Volatility modules.
Andlauer | Capex To Revenue |
Other Information on Investing in Andlauer Stock
Andlauer Healthcare financial ratios help investors to determine whether Andlauer Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Andlauer with respect to the benefits of owning Andlauer Healthcare security.